Gliomas are the most aggressive and lethal tumors of the central nervous system, for which
few therapeutic options exist. Surgical resection is the primary treatment for most gliomas; …

As the first line of host defense against pathogenic infections, innate immunity plays a key
role in antitumor immunotherapy. The cyclic GMP‐AMP synthase (cGAS)‐stimulator of …

Glioblastomas (GBMs) are aggressive primary brain tumors with fatal outcome. Traditional
chemo-radiotherapy has poor therapeutic effect and significant side effects, due to the drug …

Tumor immunosuppressive microenvironment (TIME) often causes suppression of anti-
tumor immunity and increases susceptibility to tumor recurrence and metastasis. Herein, a …

The crossing of blood–brain barrier (BBB) is essential for glioblastoma (GBM) therapy, and
homotypic targeting is an effective strategy to achieve BBB crossing. In this work, GBM …

Hydrogels have established their significance as prominent biomaterials within the realm of
biomedical research. However, injectable hydrogels have garnered greater attention …

X‐rays are rays that penetrate the human tissue and are capable of penetrating water, air,
and oxygen in various biological tissues or tumors. In recent years, significant progress has …

Integrating multimodal neuro-and nanotechnology-enabled precision immunotherapies with
extant systemic immunotherapies may finally provide a significant breakthrough for …

Low-dose radiotherapy (LDR) has shown significant implications for inflaming the
immunosuppressive tumor microenvironment (TME). Surprisingly, we identify that FABP …

Glioblastoma multiforme (GBM) is an aggressive brain cancer showing poor prognosis.
Currently, treatment methods of GBM are limited with adverse outcomes and low survival …